Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway

Molecular Therapy: Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles